Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 6 Methylthioethyl Purine 2' Deoxynucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.